Cargando…
Molecular Testing in Hematologic Malignancies
Molecular testing technologies have been increasingly integrated into clinical research and are essential tools in the care of patients with hematologic malignancies. During this session at JADPRO Live Virtual 2021, Laura J. Zitella, MS, RN, ACNP-BC, AOCN(®), reviewed key concepts for diagnostic tes...
Autor principal: | Zitella, Laura J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126340/ https://www.ncbi.nlm.nih.gov/pubmed/35663176 http://dx.doi.org/10.6004/jadpro.2022.13.3.29 |
Ejemplares similares
-
Approach to the Hospitalized Patient With Thrombocytopenia
por: Zitella, Laura J.
Publicado: (2021) -
Managing Side Effects of Cancer Patients Treated With Immunotherapy
por: Hoffner, Brianna, et al.
Publicado: (2018) -
2020–2021 Drug Updates in Hematologic Malignancies
por: Hanna, Kirollos
Publicado: (2022) -
2019–2020 Drug Updates in Hematologic Malignancies
por: Finnes, Heidi D.
Publicado: (2021) -
2018–2019 Drug Updates in Hematologic Malignancies
por: Held, Lauren
Publicado: (2020)